We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$1.36M
Cap. Flow
+$6.84M
Cap. Flow %
5.74%
Top 10 Hldgs %
39.35%
Holding
221
New
78
Increased
37
Reduced
38
Closed
48

Top Buys

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$7.97M
2
CNC icon
Centene
CNC
+$7.51M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.8M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.61M
5
LLY icon
Eli Lilly
LLY
+$2.51M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$9.46M
2
DVA icon
DaVita
DVA
+$5.09M
3
WBA
Walgreens Boots Alliance
WBA
+$3.51M
4
CAH icon
Cardinal Health
CAH
+$2.43M
5
DFS
Discover Financial Services
DFS
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 60.53%
2 Financials 20.86%
3 Miscellaneous 10.83%
4 Materials 3.73%
5 Energy 1.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPX icon
151
CALL
Compass Therapeutics
CMPX
$429M
$13.1K 0.01%
+459
New +$1.22K
VERV
152
CALL
DELISTED
Verve Therapeutics
VERV
$13K 0.01%
268
– –
SMMT icon
153
CALL
Summit Therapeutics
SMMT
$14B
$12.8K 0.01%
60
– –
SLNO
154
PUT
DELISTED
Soleno Therapeutics
SLNO
$12.7K 0.01%
533
+215
+68% +$10.5K
MODV
155
DELISTED
ModivCare
MODV
$11.5K 0.01%
8,757
– –
KROS icon
156
CALL
Keros Therapeutics
KROS
$224M
$10.8K 0.01%
354
– –
EOLS icon
157
PUT
Evolus
EOLS
$614M
$10.6K 0.01%
+115
New +$1.5K
RLAY icon
158
CALL
Relay Therapeutics
RLAY
$4.17B
$9.85K 0.01%
303
– –
MREO
159
PUT
Mereo BioPharma
MREO
$39.9M
$7.64K 0.01%
+91
New +$257
VNDA icon
160
Vanda Pharmaceuticals
VNDA
$328M
$7.13K 0.01%
+1,553
New +$7.24K
RKT icon
161
CALL
Rocket Companies
RKT
$39.8B
$6.6K 0.01%
48
-570
-92% -$7.35K
JBIO
162
PUT
Jade Biosciences
JBIO
$1.27B
$6.44K 0.01%
+10
New +$878
UBX
163
CALL
DELISTED
Unity Biotechnology
UBX
$6.06K 0.01%
801
+376
+88% +$679
IMUX icon
164
CALL
Immunic
IMUX
$179M
$5.5K ﹤0.01%
+73
New +$788
ATYR
165
PUT
aTyr Pharma
ATYR
$48.8M
$4.33K ﹤0.01%
+27
New +$98
FLNA
166
PUT
Filana Therapeutics
FLNA
$39.6M
$3.22K ﹤0.01%
24
– –
VKTX icon
167
CALL
Viking Therapeutics
VKTX
$4.07B
$3.03K ﹤0.01%
+115
New +$3.63K
ANAB icon
168
PUT
AnaptysBio
ANAB
$1.68B
$2.12K ﹤0.01%
+303
New +$5.05K
IWM icon
169
PUT
iShares Russell 2000 ETF
IWM
$81.2B
$1.43K ﹤0.01%
+238
New +$51.6K
CAPR icon
170
CALL
Capricor Therapeutics
CAPR
$547M
$525 ﹤0.01%
70
-535
-88% -$7.43K
FLNA
171
CALL
Filana Therapeutics
FLNA
$39.6M
$21 ﹤0.01%
+690
New +$1.74K
LXRX icon
172
CALL
Lexicon Pharmaceuticals
LXRX
$997M
$10 ﹤0.01%
3
– –
ANAB icon
173
CALL
AnaptysBio
ANAB
$1.68B
$9 ﹤0.01%
+236
New +$3.94K
AFRM icon
174
CALL
Affirm
AFRM
$24.4B
– –
-93
Closed -$32.2K
ALXO icon
175
CALL
ALX Oncology
ALXO
$278M
– –
-52
Closed -$260
5 6
7
8 9

Similar funds

JWM
Jessup Wealth Management Dayton, Ohio $335M AUM 56.2% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $335M AUM 97.32% 1-Year Est. Return
TFA
TPG Financial Advisors Portland, Oregon $335M AUM 14.14% 1-Year Est. Return
SIM
Seaview Investment Managers Miami, Florida $335M AUM 47.2% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $336M AUM 20.38% 1-Year Est. Return
SS
Spinecap SAS Paris, France $335M AUM 16.94% 1-Year Est. Return
BIA
BHK Investment Advisors Birmingham, Alabama $335M AUM 20.89% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Persistent Asset Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Persistent Asset Partners held 221 positions worth $119M, down 1.1% from $121M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Persistent Asset Partners deployed $6.84M of net new capital in Q1 2025, opening 78 new positions and adding to 37 existing holdings. Its largest new stake was iShares Bitcoin Trust: 150,623 shares worth $7.05M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 68% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was Humana, an estimated $9.46M trimmed.

  • Persistent Asset Partners's largest Q1 2025 buy was iShares Bitcoin Trust: 150,623 shares worth $7.05M.
  • Persistent Asset Partners added most to Centene in Q1 2025, an estimated $7.51M increase.
  • Persistent Asset Partners's biggest Q1 2025 reduction was Humana, cutting an estimated $9.46M.
  • Persistent Asset Partners fully exited Walgreens Boots Alliance in Q1 2025, selling an estimated $3.51M.
  • Persistent Asset Partners's ten largest holdings make up 39% of its $119M portfolio in Q1 2025.
  • Persistent Asset Partners opened 78 new positions and closed 48 in Q1 2025.
  • Persistent Asset Partners's portfolio value fell 1.1% quarter-over-quarter to $119M.

Based on Persistent Asset Partners's 13F filing for Q1 2025, filed 13 May 2025.